Jump to main content
United States Environmental Protection Agency
Laws & Regulations
Laws & Regulations
EPA National Library Network
Search Results for the EPA National Library Catalog
Items Found: 50
Showing: Items 1 - 50
Your Search: (SUBJECT=Pharmaceutical industry)
Publication dates (newest-oldest)
Publication dates (oldest-newest)
Choose a Library:
(CTRL-CLICK for multiple libraries)
Search all libraries
Capital Group(All DC-area libraries)
CEMM/GEMMD Library/Gulf Breeze,FL
Env Science Center Library/Ft Meade,MD
NVFEL Library/Ann Arbor, MI
OCSPP Chemical Library/Washington,DC
Region 1 Library/Boston,MA
Region 2 Library/New York,NY
Region 3 Library/Philadelphia, PA
Region 4 Library/Atlanta,GA
Region 5 Library/Chicago,IL
Region 6 Library/Dallas,TX
Region 7 IRC Library/Kansas City,KS
Region 8 Technical Library/Denver,CO
Region 9 Library/San Francisco,CA
Region 10 Library/Seattle,WA
Research Triangle Park Library/RTP, NC
Choose a Collection:
(CTRL-CLICK for multiple collections)
Search all collections
American pharmaceutical review.
Analytical methods for the determinatiion of pollutants in pharmaceutical manufacturing industry wastewater.
Analytical methods for the determination of pollutants in pharmaceutical manufacturing industry wastewater.
Biopharmaceuticals in transition
Compliance Assistance Tool for CCA Regulations: Subpart GGG of 40 CFR Part 63 - NESHAPs for Source Category Pharmaceuticals Production.
Compliance assistance tool for Clean Air Act regulations : subpart GGG of 40 CFR Part 63 NESHAPS for source category pharmaceutical production.
Compliance assistance tool for pharmaceutical production, pesticide active ingredient production, and miscellaneous organic chemical manufacturing NESHAP : comparison of regulatory requirements and case study compliance illustrations for nondedicated equipment /
Contractor's engineering report for the development of effluent limitations guidelines and standards for the pharmaceutical manufacturing industry point source category /
Cost effectiveness analysis of effluent limitations and standards for the pharmaceutical industry /
Cost effectiveness analysis of effluent standards and limitations for battery manufacturing /
Cost-effectiveness analysis of final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
Development document for effluent guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category /
Development document for effluent limitations quidelines and standards for the pharmaceutical manufacturing point source category /
Development document for final best conventional technology effluent limitations guidelines for the pharmaceutical manufacturing point source catagory.
Development document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing point source category.
Documentation basics : that support good manufacturing practices and quality system regulations /
Drug manufacturing & supply.
Drug repositioning : bringing new life to shelved assets and existing drugs /
Drug truths : dispelling the myths about pharma R & D /
Dun & Bradstreet/Gale Group industry handbook : chemicals and pharmaceuticals /
Economic analysis of effluent standards and limitations for the pharmaceutical industry /
Economic analysis of final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
Economic analysis of interim final effluent guidelines for the pharmaceutical industry : group II.
Economic analysis of proposed effluent standards and limitations for the pharmaceutical industry /
Economic impact and regulatory flexibility analysis of proposed effluent guidelines for the pharmaceutical manufacturing industry : final report.
Enhanced COD (Chemical Oxygen Demand) Removal from Pharmaceutical Wastewater Using Powdered Activated Carbon Addition to an Activated Sludge System.
Environmental assessment of the final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
Environmental assessment of the proposed effluent guidelines for the pharmaceutical manufacturing industry.
EPA Office of Compliance Sector Notebook Project. Profile of the pharmaceutical manufacturing industry.
EPA's 33/50 program company profile : Bristol-Myers Squibb Company.
Evaluation of activated carbon for enhanced COD removal from pharmaceutical wastewater /
Evaluation of activated carbon for enhanced COD removal from pharmaceutical wastewater : Volume 2. Appendices /
Glocal pharma international brands and the imagination of local masculinity / [electronic resource] :
Guides to pollution prevention : the pharmaceutical industry.
National emission standards for hazardous air pollutants (NESHAP) for the pharmaceutical manufacturing industry : background information for promulgated standards, summary of public comments and responses /
OPD chemical buyers directory.
Permit guidance document : pharmaceutical manufacturing point source category (40 CFR Part 439) /
Pharmaceutical industry : hazardous waste generation, treatment, and disposal.
Pollution prevention assessment for a manufacturer of pharmaceuticals /
Preliminary data summary for the pharmaceutical manufacturing point source category.
Product development planning for health care products regulated by the FDA
Re-inventing drug development /
Regulatory impact assessment of proposed effluent guidelines for the pharmaceutical manufacturing industry : final report.
Statistical support document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
Volatile organic compound emission controls for tablet coating at pharmaceutical plants /
Waste audit study, drug manufacturing and processing industry
Waste treatment and disposal methods for the pharmaceutical industry /
Save, Print or Email Selected Records
Selected (this page only)
Selected (across pages)
All (this page only)
All (all pages - 500 item maximum)
Text (Brief Information)
Text (Full Information)
Endnote (Endnote Import)
ASCII delimited for EXCEL